CMA1
Basic information
Region (hg38): 14:24505353-24508265
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CMA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 0 |
Variants in CMA1
This is a list of pathogenic ClinVar variants found in the CMA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-24505556-T-G | not specified | Uncertain significance (Mar 19, 2024) | ||
14-24505611-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
14-24505634-C-G | not specified | Uncertain significance (May 31, 2023) | ||
14-24506060-C-T | not specified | Uncertain significance (May 05, 2023) | ||
14-24506065-C-A | not specified | Uncertain significance (Dec 28, 2023) | ||
14-24506081-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
14-24506119-A-G | not specified | Uncertain significance (Nov 09, 2022) | ||
14-24506140-T-C | not specified | Uncertain significance (Dec 07, 2021) | ||
14-24506158-G-A | not specified | Uncertain significance (Oct 06, 2023) | ||
14-24506160-C-A | not specified | Uncertain significance (Jun 17, 2024) | ||
14-24506194-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
14-24506558-C-A | not specified | Uncertain significance (Feb 28, 2024) | ||
14-24506604-C-T | not specified | Likely benign (Nov 03, 2023) | ||
14-24507388-G-T | not specified | Uncertain significance (Oct 03, 2022) | ||
14-24507392-C-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
14-24507420-T-C | not specified | Uncertain significance (Dec 03, 2021) | ||
14-24507429-C-G | Likely benign (Mar 28, 2018) | |||
14-24507430-G-T | not specified | Uncertain significance (Dec 26, 2023) | ||
14-24507488-G-C | not specified | Uncertain significance (Jul 06, 2021) | ||
14-24507495-C-T | not specified | Uncertain significance (Jun 27, 2022) | ||
14-24508192-G-C | not specified | Uncertain significance (May 20, 2024) | ||
14-24508196-A-G | not specified | Uncertain significance (Apr 08, 2024) | ||
14-24508216-G-C | not specified | Uncertain significance (Mar 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CMA1 | protein_coding | protein_coding | ENST00000250378 | 5 | 2913 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.59e-9 | 0.0431 | 125014 | 4 | 714 | 125732 | 0.00286 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.75 | 201 | 142 | 1.41 | 0.00000782 | 1589 |
Missense in Polyphen | 76 | 51.795 | 1.4673 | 604 | ||
Synonymous | -1.90 | 74 | 55.9 | 1.32 | 0.00000300 | 519 |
Loss of Function | -0.806 | 11 | 8.47 | 1.30 | 3.56e-7 | 112 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00602 | 0.00604 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0314 | 0.0314 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000795 | 0.0000791 |
Middle Eastern | 0.0314 | 0.0314 |
South Asian | 0.000392 | 0.000392 |
Other | 0.00147 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Major secreted protease of mast cells with suspected roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion.;
- Pathway
- Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics;Renin-angiotensin system - Homo sapiens (human);ACE Inhibitor Pathway, Pharmacodynamics;Lung fibrosis;ACE Inhibitor Pathway;Signal Transduction;Peptide hormone metabolism;Metabolism of proteins;Metabolism of Angiotensinogen to Angiotensins;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Degradation of the extracellular matrix;Signaling by SCF-KIT;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.626
Intolerance Scores
- loftool
- 0.477
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.19
Haploinsufficiency Scores
- pHI
- 0.131
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.403
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.138
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cma1
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- angiotensin maturation;extracellular matrix disassembly;midbrain development;basement membrane disassembly;positive regulation of angiogenesis;interleukin-1 beta biosynthetic process;regulation of inflammatory response;cellular response to glucose stimulus
- Cellular component
- extracellular region;extracellular space;cytoplasm;secretory granule;collagen-containing extracellular matrix
- Molecular function
- endopeptidase activity;serine-type endopeptidase activity;serine-type peptidase activity;peptide binding